Title : Novel Hypolipidaemic Drugs: Mechanisms of Action and Main Metabolic Effects - Filippatos_2019_Curr.Vasc.Pharmacol_17_332 |
Author(s) : Filippatos TD , Liontos A , Christopoulou EC , Elisaf MS |
Ref : Curr Vasc Pharmacol , 17 :332 , 2019 |
Abstract : |
PubMedSearch : Filippatos_2019_Curr.Vasc.Pharmacol_17_332 |
PubMedID: 29424317 |
Title : The pharmacokinetic considerations and adverse effects of DDP-4 inhibitors - Filippatos_2014_Expert.Opin.Drug.Metab.Toxicol_10_787 |
Author(s) : Filippatos TD , Athyros VG , Elisaf MS |
Ref : Expert Opin Drug Metab Toxicol , 10 :787 , 2014 |
Abstract : |
PubMedSearch : Filippatos_2014_Expert.Opin.Drug.Metab.Toxicol_10_787 |
PubMedID: 24746233 |
Title : Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A(2) in subjects with prediabetes - Filippatos_2013_Lipids_48_547 |
Author(s) : Filippatos TD , Rizos EC , Tsimihodimos V , Gazi IF , Tselepis AD , Elisaf MS |
Ref : Lipids , 48 :547 , 2013 |
Abstract : |
PubMedSearch : Filippatos_2013_Lipids_48_547 |
PubMedID: 23546765 |
Title : The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia - Agouridis_2011_Expert.Opin.Pharmacother_12_2605 |
Author(s) : Agouridis AP , Tsimihodimos V , Filippatos TD , Dimitriou AA , Tellis CC , Elisaf MS , Mikhailidis DP , Tselepis AD |
Ref : Expert Opin Pharmacother , 12 :2605 , 2011 |
Abstract : |
PubMedSearch : Agouridis_2011_Expert.Opin.Pharmacother_12_2605 |
PubMedID: 21714585 |
Title : Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased high-density lipoprotein - Gazi_2011_Lipids_46_953 |
Author(s) : Gazi IF , Apostolou FA , Liberopoulos EN , Filippatos TD , Tellis CC , Elisaf MS , Tselepis AD |
Ref : Lipids , 46 :953 , 2011 |
Abstract : |
PubMedSearch : Gazi_2011_Lipids_46_953 |
PubMedID: 21688175 |
Title : Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia - Kostapanos_2009_J.Cardiovasc.Pharmacol.Ther_14_5 |
Author(s) : Kostapanos MS , Milionis HJ , Filippatos TD , Christogiannis LG , Bairaktari ET , Tselepis AD , Elisaf MS |
Ref : J Cardiovasc Pharmacol Ther , 14 :5 , 2009 |
Abstract : |
PubMedSearch : Kostapanos_2009_J.Cardiovasc.Pharmacol.Ther_14_5 |
PubMedID: 19246334 |
Title : Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome - Lagos_2009_Lipids_44_9 |
Author(s) : Lagos KG , Filippatos TD , Tsimihodimos V , Gazi IF , Rizos C , Tselepis AD , Mikhailidis DP , Elisaf MS |
Ref : Lipids , 44 :9 , 2009 |
Abstract : |
PubMedSearch : Lagos_2009_Lipids_44_9 |
PubMedID: 18956219 |
Title : The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia - Nakou_2008_Expert.Opin.Pharmacother_9_3151 |
Author(s) : Nakou ES , Filippatos TD , Kiortsis DN , Derdemezis CS , Tselepis AD , Mikhailidis DP , Elisaf MS |
Ref : Expert Opin Pharmacother , 9 :3151 , 2008 |
Abstract : |
PubMedSearch : Nakou_2008_Expert.Opin.Pharmacother_9_3151 |
PubMedID: 19040336 |
Title : Orlistat-associated adverse effects and drug interactions: a critical review - Filippatos_2008_Drug.Saf_31_53 |
Author(s) : Filippatos TD , Derdemezis CS , Gazi IF , Nakou ES , Mikhailidis DP , Elisaf MS |
Ref : Drug Safety , 31 :53 , 2008 |
Abstract : |
PubMedSearch : Filippatos_2008_Drug.Saf_31_53 |
PubMedID: 18095746 |